About CapCo Bio
CapCo Bio is a company based in Freiburg (Germany) founded in 2020 by Arnold Martin. CapCo Bio offers products and services including Nanocapsules and siRNA CAPSULON. CapCo Bio operates in a competitive market with competitors including Sirnaomics, Ensysce, Arcturus Therapeutics, EryDel and ViAqua, among others.
- Headquarter Freiburg, Germany
- Founders Arnold Martin
- SectorsTechnologyHealthcare
- Email••••••••
- Phone•••• ••••
- Website capcobio.de
- Social LinkedIn
- Legal Name Capco Bio Gmbh
Products & Services of CapCo Bio
CapCo Bio offers a comprehensive portfolio of products and services, including Nanocapsules and siRNA CAPSULON.
Biodegradable carriers for efficient drug and gene delivery
Kits for nucleic acid transfection using synthetic nanocapsules
People of CapCo Bio
1 people are tracked at CapCo Bio (1 in leadership).
| Name | Role | Group |
|---|---|---|
Arnold Martin | Co-Founder & CEO | Leadership |
Complete people profiles for CapCo Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of CapCo Bio
CapCo Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sirnaomics, Ensysce, Arcturus Therapeutics, EryDel and ViAqua, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sirnaomics.com | 2007 | Gaithersburg, United States | $267M | 88 | RNA-based therapeutics for cancer and fibrosis are developed. | |
| ensysce.com | 2008 | Houston, United States | $2.5M | – | Drug delivery solutions via single-walled carbon nanotubes are offered. | |
| arcturusrx.com | 2013 | San Diego, United States | $1.3M | 337 | RNAi technologies are developed for treating rare orphan diseases. | |
| erydel.com | 2007 | Milan, Italy | $31.7M | – | Erythrocyte encapsulation systems for drug delivery are developed. | |
| viaqua-t.com | 2014 | Rehovot, Israel | $12.55M | – | RNAi drug delivery technology is developed for aquaculture disease prevention. | |
| zylotherapeutics.com | 2017 | Greenville, United States | $9.43M | – | Hydrogel-derived nanoparticles for topical drug delivery are developed. | |
| vaxxas.com | 2010 | Sydney, Australia | $108.48M | – | Developer of vaccines to treat cancer and infectious diseases | |
| topas-therapeutics.com | 2016 | Hamburg, Germany | $67.46M | 14 | Nanoparticle-based therapeutics for immunology disorders are developed. | |
| aphios.com | 1993 | Boston, United States | – | 6 | Therapeutics for cancer and infectious diseases are developed. | |
| splice.bio | 2020 | Barcelona, Spain | $191.7M | – | Provider of a proprietary platform for gene therapy |
Detailed competitors of CapCo Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CapCo Bio
Websites that share an audience with CapCo Bio (capcobio.de).
Websites whose visitors overlap most with CapCo Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rheintacho.de | 100% | – | – | View details | |
cadida.de | cadida.de | 98% | – | #12,968,560 | – |
| stockert.de | 96% | – | – | View details | |
iic-ag.com | iic-ag.com | 96% | – | – | – |
kersten.de | kersten.de | 94% | – | #9,852,273 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for CapCo Bio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to CapCo Bio
10 companies that operate in the same segment as CapCo Bio (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CapCo Bio
CapCo Bio was founded in 2020.
CapCo Bio is headquartered in Freiburg, Germany. It is registered at Freiburg, Baden-wurttemberg, Germany.
Arnold Martin is the current CEO of CapCo Bio. They have also founded this company.
CapCo Bio was established in 2020 in Freiburg, Germany, within the biotechnology sector. Nanocapsules are engineered for the targeted delivery of biomolecules such as proteins, nucleic acids, peptides, and small molecules. A nanocarriers platform is provided to facilitate compound transport in therapeutic applications. Operations emphasize innovation in drug delivery systems, with focus on scalability and efficacy for pharmaceutical uses.
CapCo Bio's top competitors include Sirnaomics, Arcturus Therapeutics and Splice Bio.
CapCo Bio offers Nanocapsules and siRNA CAPSULON.
CapCo Bio operates through Capco Bio Gmbh.